COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients
β Scribed by Johanna G. H. van Nes; Esther M. de Kruijf; Dana Faratian; Cornelis J. H. van de Velde; Hein Putter; Claire Falconer; Vincent T. H. B. M. Smit; Charlene Kay; Marc J. van de Vijver; Peter J. K. Kuppen; John M. S. Bartlett
- Book ID
- 106378702
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 520 KB
- Volume
- 125
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The prognostic significance of __BRCA2__ mRNA levels in tumor tissues was studied in sporadic breast cancer patients. __BRCA2__ mRNA levels were determined by realβtime PCR. Histologic grade III tumors showed significantly (__p__ = 0.001) higher __BRCA2__ mRNA levels (0.828 Β± 0.102 __BR
## Abstract The tumor suppressor gene __maspin__ has been reported to inhibit the invasiveness and motility of breast cancer cells. It has been reported that maspin is expressed in normal human mammary epithelial cells but is downregulated during cancer progression, and that p53 could induce maspin